May 19, 2009 (FinancialWire) — Gen-Probe Inc. (NASDAQ: GPRO) said that Carl W. Hull has formally succeeded the company’s long-time leader, Henry L. Nordhoff, as chief executive officer. Hull, formerly Gen-Probe’s president and chief operating officer, also has joined the company’s board.

Nordhoff, who had served as Gen-Probe’s CEO since 1994, retired as CEO on May 17. Nordhoff is now non-executive chairman following his re-election to the board at the company’s annual meeting last week.

San Diego-based Gen-Probe is engaged in the development, manufacture and marketing of nucleic acid tests that are used primarily to diagnose human diseases and screen donated human blood.

Gen-Probe employs around 1,200 people.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.